Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study.

Gradishar, William J

Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Jun 2004 - 2321-7 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0732-183X

10.1200/JCO.2004.12.128 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Capecitabine
Deoxycytidine--administration & dosage
Disease Progression
Female
Fluorouracil--analogs & derivatives
Humans
Middle Aged
Neoplasm Recurrence, Local
Paclitaxel--administration & dosage
Survival Analysis
Time Factors
Treatment Outcome